Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
...
Views
Read Time
...
views
Read Time
Is Bladder Cancer Curable? Spread Facts
Is Bladder Cancer Curable? Spread Facts 4

Receiving a diagnosis of bladder cancer can be overwhelming, but understanding the condition is key to navigating the treatment journey. Bladder cancer occurs when abnormal cells in the bladder grow uncontrollably, forming a tumor.

Early detection significantly improves the chances of successful treatment. Recognizing bladder cancer symptoms, such as blood in the urine or changes in urination habits, is crucial. Understanding what causes bladder cancer can also help identify risk factors and potentially prevent the disease.

The question on everyone’s mind is: is bladder cancer curable? The answer lies in the stage and type of cancer, as well as the effectiveness of the chosen treatment plan.

Key Takeaways

  • Bladder cancer is treatable when detected early.
  • Understanding the causes and risk factors can help prevention.
  • Recognizing symptoms is crucial for early detection.
  • The curability of bladder cancer depends on the stage and type.
  • Effective treatment plans can significantly improve outcomes.

Understanding Bladder Cancer and Urothelial Carcinoma

Is Bladder Cancer Curable? Spread Facts
Is Bladder Cancer Curable? Spread Facts 5

Bladder cancer, primarily known as urothelial carcinoma, is a significant health concern that requires comprehensive understanding. It arises from the urothelial cells that line the inside of the bladder.

What is Bladder Cancer?

Is Bladder Cancer Curable? Spread Facts
Is Bladder Cancer Curable? Spread Facts 6

Bladder cancer occurs when the cells in the bladder grow abnormally, forming a tumor. This type of cancer is more common in men than women and is often diagnosed in people over 55.

The bladder’s function is to store urine, and cancer can disrupt this process. Early detection is crucial for effective treatment.

Types of Bladder Cancer

There are several types of bladder cancer, with urothelial carcinoma being the most common, accounting for about 90% of cases.

  • Urothelial Carcinoma: Begins in the urothelial cells.
  • Squamous Cell Carcinoma: Associated with chronic irritation, often linked to schistosomiasis.
  • Adenocarcinoma: A rare type that starts in the glandular cells.

Risk Factors for Bladder Cancer

Understanding the risk factors can help in prevention and early detection. Some of the key risk factors include:

  1. Smoking: A significant risk factor as it exposes the bladder to harmful chemicals.
  2. Chemical exposure: Certain industrial chemicals can increase the risk.
  3. Chronic irritation: Conditions like schistosomiasis can lead to squamous cell carcinoma.
  4. Age and gender: More common in older men.

The presence of squamous epithelial cells in urine can sometimes indicate a risk or presence of bladder cancer, particularly squamous cell carcinoma.

“The risk factors for bladder cancer highlight the importance of lifestyle changes and awareness, especially for those with a history of smoking or exposure to certain chemicals.”

Early Signs and Symptoms of Bladder Cancer

Understanding the symptoms associated with bladder cancer can significantly impact treatment outcomes. Bladder cancer often presents with symptoms that can be similar to those of less serious conditions, making it crucial to be aware of the specific signs that may indicate its presence.

Common Symptoms to Look For

The symptoms of bladder cancer can vary, but there are several common signs to be aware of. These include:

  • Hematuria, or blood in the urine, which is the most common symptom.
  • Frequent urination or a sense of urgency.
  • Pain or burning during urination.
  • Back or pelvic pain.

It’s essential to note that these symptoms can also be associated with other conditions. However, if you experience any of these, especially hematuria, it’s crucial to consult a healthcare professional.

When to See a Doctor

If you’re experiencing any of the symptoms mentioned, it’s vital to schedule an appointment with your doctor. Early detection can significantly improve treatment outcomes for bladder cancer.

Your doctor will likely perform a series of tests, including urine analysis, imaging tests, and possibly a cystoscopy, to determine the cause of your symptoms.

Symptom

Description

Hematuria

Blood in the urine, which can be visible or detected through tests.

Frequent Urination

Needing to urinate more often than usual.

Painful Urination

Experiencing pain or a burning sensation while urinating.

Staging and Grading of Bladder Cancer

Understanding the extent and severity of bladder cancer is crucial for determining the best course of treatment, which is achieved through staging and grading. Staging refers to the process of determining how far the cancer has spread, while grading refers to the examination of cancer cells to understand their characteristics.

What Does Staging Mean?

Staging is a critical step in bladder cancer diagnosis. It helps doctors understand whether the cancer is limited to the bladder or has spread to other parts of the body. The most commonly used staging system for bladder cancer is the TNM system, which considers the size and extent of the main tumor (T), whether the cancer has spread to nearby lymph nodes (N), and whether the cancer has metastasized (M).

The stages of bladder cancer are typically categorized as follows:

  • Stage I: Cancer is limited to the bladder’s inner layer.
  • Stage II: Cancer has grown into the bladder muscle.
  • Stage III: Cancer has spread beyond the bladder to nearby tissues.
  • Stage IV: Cancer has spread to distant parts of the body or to lymph nodes outside the pelvis.

Importance of Grading

Grading is another vital aspect of bladder cancer diagnosis. It involves examining the cancer cells under a microscope to determine their grade. The grade indicates how much the cancer cells resemble normal cells. The grading system typically used for bladder cancer ranges from low grade to high grade.

Low-grade cancers look more like normal bladder cells and tend to grow and spread slowly. In contrast, high-grade cancers look more abnormal and are more likely to grow and spread quickly. The grade of the cancer helps doctors predict the likely course of the disease and decide on the most appropriate treatment plan.

Treatment Options for Bladder Cancer

Treatment for bladder cancer can involve a combination of surgery, chemotherapy, and immunotherapy. The choice of treatment depends on the stage, grade, and overall health of the patient.

Surgery: Types and Procedures

Surgery is a primary treatment for bladder cancer, with various procedures available depending on the cancer’s stage and the patient’s condition.

  • Transurethral Resection of Bladder Tumor (TURBT): A procedure used to diagnose and treat early-stage bladder cancer by removing the tumor from the bladder wall.
  • Radical Cystectomy: Involves removing the bladder, nearby lymph nodes, and part of the urethra. In men, this may also include removing the prostate and seminal vesicles.
  • Partial Cystectomy: Removing part of the bladder, usually considered for patients with a single tumor in a specific location.

Each surgical procedure has its benefits and risks, and the choice depends on the individual case.

Chemotherapy: How It Works

Chemotherapy is a treatment that uses drugs to kill cancer cells. For bladder cancer, chemotherapy can be administered:

  • Intravesical Chemotherapy: Directly delivered into the bladder through a catheter to treat early-stage bladder cancer.
  • Systemic Chemotherapy: Given orally or intravenously to treat cancer that has spread beyond the bladder.

Chemotherapy can be used before surgery to shrink tumors or after surgery to kill any remaining cancer cells.

Immunotherapy: A New Approach

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. For bladder cancer, BCG (Bacillus Calmette-Guérin) immunotherapy is commonly used, delivered directly into the bladder through a catheter.

Immunotherapy can help reduce the risk of cancer recurrence and progression.

Treatment

Description

Use Case

Surgery (TURBT)

Removes tumor from bladder wall

Early-stage bladder cancer

Radical Cystectomy

Removes bladder, lymph nodes, and part of urethra

Advanced bladder cancer

Intravesical Chemotherapy

Delivers drugs directly into bladder

Early-stage bladder cancer

BCG Immunotherapy

Stimulates immune system to fight cancer

Reducing recurrence risk

Understanding Recurrence of Bladder Cancer

Understanding the risk of recurrence is crucial for bladder cancer patients. After undergoing treatment, patients often wonder about the likelihood of the cancer returning and what signs to watch out for.

Chances of Recurrence

The risk of bladder cancer recurrence varies depending on several factors, including the stage and grade of the initial cancer, the effectiveness of the treatment, and the patient’s overall health. Studies indicate that recurrence can happen in up to 50% of cases within the first year after treatment, emphasizing the need for regular follow-ups.

Key factors influencing recurrence include:

  • The stage and grade of the initial tumor
  • The presence of carcinoma in situ
  • The completeness of the initial treatment
  • Patient’s smoking status

Identifying Signs of Recurrence

Recognizing the signs of recurrence early is vital for timely intervention. Common signs include:

  1. Blood in the urine (hematuria)
  2. Increased frequency or urgency of urination
  3. Painful urination
  4. Back or pelvic pain

It’s also worth noting that recurrent urinary tract infections (UTIs) can sometimes be a sign of bladder cancer recurrence, although UTIs are common and usually have other causes. If you’re experiencing recurrent UTIs or any of the above symptoms, it’s essential to consult your healthcare provider.

Regular check-ups and maintaining a healthy lifestyle can help in early detection and management of recurrence.

Is Bladder Cancer Curable?

Understanding whether bladder cancer is curable requires examining various influencing factors. The prognosis and survival rate of bladder cancer patients have seen significant improvements due to advancements in medical treatments and early detection methods.

Factors Influencing Curability

Several factors play a crucial role in determining the curability of bladder cancer. These include:

  • Stage at Diagnosis: Early-stage bladder cancer is more likely to be cured than advanced stages.
  • Type of Bladder Cancer: The type of bladder cancer, such as urothelial carcinoma, can influence treatment options and curability.
  • Overall Health: A patient’s overall health and presence of other medical conditions can affect their ability to undergo certain treatments.
  • Response to Treatment: How well the cancer responds to initial treatment is a significant indicator of curability.

Survivor Stories and Statistics

Survivor stories provide hope and insight into the journey of living with bladder cancer. According to the American Cancer Society, the 5-year survival rate for bladder cancer is around 77%. However, this rate varies significantly based on the stage at diagnosis.

“I was diagnosed with early-stage bladder cancer, and after treatment, I’ve been cancer-free for five years now. It’s a journey, but with the right support and treatment, it’s possible to overcome it.”

— Sarah, Bladder Cancer Survivor

Statistics show that:

  1. The survival rate for bladder cancer confined to the bladder wall is much higher than for cancer that has spread to distant parts of the body.
  2. Advancements in treatments such as immunotherapy and targeted therapy have improved survival rates.
  3. Regular follow-ups and check-ups are crucial for early detection of recurrence.

These stories and statistics highlight the importance of early detection, appropriate treatment, and ongoing support in the journey towards curing bladder cancer.

Living with Bladder Cancer

Living with bladder cancer requires not just medical treatment, but a holistic approach to health and well-being. The diagnosis can be overwhelming, but with the right support and resources, patients can navigate this challenging journey.

Coping with the Diagnosis

Coping with a bladder cancer diagnosis involves both emotional and practical adjustments. It’s essential for patients to understand their diagnosis and the available treatment options. A urologist plays a crucial role in this process, as they specialize in the diagnosis, treatment, and management of urinary tract conditions, including bladder cancer. Understanding the urologist’s role can help patients make informed decisions about their care.

Support Groups and Resources

Support groups and resources are vital for patients living with bladder cancer. These groups provide a platform for sharing experiences, receiving emotional support, and gaining insights into managing the condition. Some notable resources include:

  • Cancer support organizations
  • Online forums and communities
  • Local support groups
  • Patient advocacy groups

Emotional support is crucial for coping with the diagnosis. Patients often benefit from counseling or therapy to deal with the emotional impact. Practically, patients can prepare for treatment by understanding the potential side effects and how to manage them.

Resource

Description

Contact Information

CancerCare

Provides free support services to people with cancer

1-800-813-HOPE (4673)

Bladder Cancer Advocacy Network (BCAN)

Offers support, education, and advocacy for bladder cancer patients

1-888-682-2226

“The greatest glory in living lies not in never falling, but in rising every time we fall.” – Nelson Mandela

This quote encapsulates the resilience required to cope with a bladder cancer diagnosis.

Living with bladder cancer is a journey that requires comprehensive support, including medical treatment, emotional coping strategies, and access to resources. By understanding the condition and leveraging available support, patients can improve their quality of life.

The Role of Lifestyle in Bladder Cancer

Adopting a healthy lifestyle can play a significant role in managing and potentially reducing the risk of bladder cancer. Lifestyle factors such as diet, nutrition, exercise, and mental health are crucial in determining the overall well-being of individuals, especially those diagnosed with bladder cancer.

Diet and Nutrition

A well-balanced diet rich in fruits, vegetables, and whole grains can help manage bladder cancer. Certain foods have been identified as potentially beneficial due to their antioxidant properties.

  • Fruits and Vegetables: High in antioxidants, they help protect cells from damage.
  • Whole Grains: Rich in fiber, which can help maintain a healthy digestive system.
  • Omega-3 Fatty Acids: Found in fish like salmon, they are known for their anti-inflammatory properties.

Avoiding certain foods and substances can also be beneficial. For instance, reducing intake of processed meats and foods high in salt can contribute to overall health.

Food Group

Beneficial Foods

Foods to Limit

Fruits and Vegetables

Citrus fruits, leafy greens

Pickled or canned vegetables

Proteins

Lean meats, fish, eggs

Processed meats

Grains

Whole grains, oats

Refined grains

Exercise and Mental Health

Regular physical activity not only improves physical health but also has a positive impact on mental well-being. Exercise can help reduce stress and anxiety, common among cancer patients.

Simple exercises like walking, yoga, or light swimming can be very beneficial. It’s essential to consult with a healthcare provider before starting any new exercise regimen, especially for those undergoing cancer treatment.

Mental health support is equally important. Connecting with support groups, either in-person or online, can provide emotional support and help individuals cope with their diagnosis.

  • Stress Reduction Techniques: Practices like meditation and deep breathing can help manage stress.
  • Support Groups: Sharing experiences with others facing similar challenges can be very comforting.

By focusing on diet, nutrition, exercise, and mental health, individuals can take proactive steps towards managing bladder cancer and improving their quality of life.

Future of Bladder Cancer Treatments

The landscape of bladder cancer treatment is evolving rapidly, driven by advancements in research and technology. As a result, patients are benefiting from a wider range of effective treatment options.

Advancements in Research and Clinical Trials

Research into bladder cancer is ongoing, with numerous clinical trials investigating new treatments and therapies. These trials are crucial for improving our understanding of the disease and developing more effective treatments.

Key areas of research include:

  • Investigating the role of genetics in bladder cancer
  • Developing targeted therapies that attack cancer cells more precisely
  • Improving immunotherapy treatments to boost the body’s immune response

A recent study highlighted the potential of a new therapeutic approach, showing a significant reduction in tumor size in participants. Such advancements underscore the importance of continued research and investment in clinical trials.

Research Area

Potential Benefits

Current Status

Genetic Research

Personalized treatment plans based on genetic markers

Ongoing clinical trials

Targeted Therapies

More precise treatment with fewer side effects

Promising early results

Immunotherapy

Enhanced immune response against cancer cells

Approved for certain patient groups

Emerging Therapies

Emerging therapies offer new hope for bladder cancer patients, particularly those with advanced or recurrent disease. These therapies are being developed based on a deeper understanding of the biology of bladder cancer.

Some of the most promising emerging therapies include:

  1. Checkpoint inhibitors, which release the brakes on the immune system’s response to cancer
  2. Antibody-drug conjugates, which deliver chemotherapy directly to cancer cells
  3. Gene therapies, aimed at correcting the genetic abnormalities driving the cancer

As these therapies move through clinical trials, they hold the potential to significantly improve outcomes for bladder cancer patients.

Frequently Asked Questions About Bladder Cancer

As bladder cancer affects more people, the need for clear and concise information becomes increasingly important. Patients and their families often have numerous questions about the disease, its treatment, and what to expect.

What Is the Survival Rate?

The survival rate for bladder cancer depends on several factors, including the stage and grade of the cancer at diagnosis. Generally, the five-year survival rate for bladder cancer is around 77% for people diagnosed at any stage. However, this rate can vary significantly based on whether the cancer is localized, regional, or distant.

Stage at Diagnosis

Five-Year Survival Rate

Localized

96%

Regional

69%

Distant

31%

Can Bladder Cancer Be Prevented?

While not all cases of bladder cancer can be prevented, there are certain lifestyle changes and precautions that can reduce the risk. Quitting smoking is one of the most significant steps, as smoking is a major risk factor for bladder cancer. Additionally, limiting exposure to certain chemicals and maintaining a healthy diet rich in fruits and vegetables can also help.

Some of the key preventive measures include:

  • Avoiding smoking and tobacco products
  • Reducing exposure to industrial chemicals
  • Drinking plenty of water to help flush out potential carcinogens
  • Eating a balanced diet

Understanding these aspects can empower individuals to take proactive steps towards reducing their risk of developing bladder cancer.

Conclusion: Hope and Resources in the Journey

As we conclude our exploration of bladder cancer, it’s clear that understanding this disease is crucial for early detection and effective treatment. The journey through diagnosis, treatment, and beyond can be challenging, but there is hope and support available.

Key Takeaways

Bladder cancer, particularly urothelial carcinoma, requires awareness of its risk factors, symptoms, and treatment options. By understanding the staging and grading of the disease, patients can better navigate their care paths.

Finding Support

For those affected by bladder cancer, numerous resources are available, including support groups, nutritional guidance, and emerging therapies. Organizations dedicated to cancer research and patient support offer valuable information and community.

By staying informed and connected, individuals can find the hope and resources needed to face bladder cancer. For more information on bladder cancer and to find support, visit reputable health organizations’ websites.

FAQ

What are the early warning signs of bladder cancer?

Common symptoms include blood in the urine, frequent urination, painful urination, and abdominal pain. If you experience any of these, it’s crucial to consult a doctor.

Can recurrent UTIs be a sign of bladder cancer?

While UTIs are typically not a sign of cancer, recurrent UTIs can be a symptom of an underlying issue, including bladder cancer. It’s essential to get checked by a healthcare professional.

What is urothelial carcinoma?

Urothelial carcinoma, also known as transitional cell carcinoma, is the most common type of bladder cancer. It begins in the urothelial cells that line the inside of the bladder.

How is bladder cancer staged and graded?

Staging refers to the extent of the cancer, while grading refers to the appearance of the cancer cells. Both are crucial for determining the best treatment approach.

What are the treatment options for bladder cancer?

Treatment options include surgery, chemotherapy, immunotherapy, and radiation therapy. The choice of treatment depends on the stage and grade of the cancer.

Can bladder cancer be cured?

Yes, bladder cancer can be cured, especially if it’s diagnosed at an early stage. Treatment outcomes vary depending on the stage and overall health.

What is the role of a urologist in treating bladder cancer?

A urologist specializes in the diagnosis and treatment of urinary tract conditions, including bladder cancer. They play a crucial role in managing the disease.

Are there any lifestyle changes that can help prevent bladder cancer?

While there’s no guaranteed way to prevent bladder cancer, maintaining a healthy lifestyle, including a balanced diet and not smoking, can reduce the risk.

What is the survival rate for bladder cancer?

The survival rate varies depending on the stage at diagnosis. Early-stage bladder cancer has a higher survival rate compared to advanced stages.

Can stress cause cancer?

There’s no conclusive evidence that stress directly causes cancer. However, chronic stress can impact overall health and potentially influence cancer progression.

What is the significance of squamous epithelial cells in urine?

The presence of squamous epithelial cells in urine can be a normal finding, but in some cases, it may indicate an underlying condition, including bladder cancer or schistosomiasis.

What is schistosomiasis, and how is it related to bladder cancer?

Schistosomiasis is a parasitic infection that can cause bladder damage and increase the risk of developing bladder cancer, particularly squamous cell carcinoma.

Reference

National Center for Biotechnology Information. Evidence-Based Medical Insight. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC12223361/

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Evrim Duman Liv Hospital Ulus Assoc. Prof. MD. Evrim Duman Radiation Oncology Asst. Prof. MD. Meltem Topalgökçeli Selam Liv Hospital Ulus Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology Prof. MD. Duygu Derin Liv Hospital Ulus Prof. MD. Duygu Derin Medical Oncology Prof. MD. Emre Merdan Fayda Liv Hospital Ulus Prof. MD. Emre Merdan Fayda Radiation Oncology Prof. MD. Meral Günaldı Liv Hospital Ulus Prof. MD. Meral Günaldı Medical Oncology Assoc. Prof. MD. Murat Ayhan Liv Hospital Vadistanbul Assoc. Prof. MD. Murat Ayhan Medical Oncology Prof. MD.  Itır Şirinoğlu Demiriz Liv Hospital Vadistanbul Prof. MD. Itır Şirinoğlu Demiriz Hematology Prof. MD. Tülin Tıraje Celkan Liv Hospital Vadistanbul Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology Assoc. Prof. MD. Erkan Kayıkçıoğlu Liv Hospital Bahçeşehir Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology Assoc. Prof. MD. Mine Dağgez Liv Hospital Bahçeşehir Assoc. Prof. MD. Mine Dağgez Gynecological Oncology Assoc. Prof. MD. Ozan Balakan Liv Hospital Bahçeşehir Assoc. Prof. MD. Ozan Balakan Medical Oncology MD. Taylan Bükülmez Liv Hospital Bahçeşehir MD. Taylan Bükülmez Radiation Oncology Op. MD. Alp Koray Kinter Liv Hospital Bahçeşehir Op. MD. Alp Koray Kinter Gynecological Oncology Prof. MD. Nuri Faruk Aykan Liv Hospital Bahçeşehir Prof. MD. Nuri Faruk Aykan Medical Oncology Prof. MD. Yasemin Altuner Torun Liv Hospital Bahçeşehir Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology Spec. MD. Özlem Doğan Liv Hospital Bahçeşehir Spec. MD. Özlem Doğan Medical Oncology Assoc. Prof. MD. Emir Çelik Liv Hospital Topkapı Assoc. Prof. MD. Emir Çelik Medical Oncology Assoc. Prof. MD. Muhammed Mustafa Atcı Liv Hospital Topkapı Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology Prof. MD. İrfan Çiçin Liv Hospital Topkapı Prof. MD. İrfan Çiçin Medical Oncology Assoc. Prof. MD.  Ramazan Öcal Liv Hospital Ankara Assoc. Prof. MD. Ramazan Öcal Hematology Assoc. Prof. MD. Nazlı Topfedaisi Özkan Liv Hospital Ankara Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology Prof. MD. Fikret Arpacı Liv Hospital Ankara Prof. MD. Fikret Arpacı Medical Oncology Prof. MD. Gökhan Erdem Liv Hospital Ankara Prof. MD. Gökhan Erdem Medical Oncology Prof. MD. Meral Beksaç Liv Hospital Ankara Prof. MD. Meral Beksaç Hematology Prof. MD. Oral Nevruz Liv Hospital Ankara Prof. MD. Oral Nevruz Hematology Prof. MD. Saadettin Kılıçkap Liv Hospital Ankara Prof. MD. Saadettin Kılıçkap Medical Oncology Prof. MD. Sadık Muallaoğlu Liv Hospital Ankara Prof. MD. Sadık Muallaoğlu Medical Oncology Spec. MD. Ender Kalacı Liv Hospital Ankara Spec. MD. Ender Kalacı Medical Oncology Assoc. Prof. MD. Fadime Ersoy Dursun Liv Hospital Gaziantep Assoc. Prof. MD. Fadime Ersoy Dursun Hematology Prof. MD. Fatih Teker Liv Hospital Gaziantep Prof. MD. Fatih Teker Medical Oncology Spec. MD. ELXAN MEMMEDOV Liv Bona Dea Hospital Bakü Spec. MD. ELXAN MEMMEDOV Medical Oncology Spec. MD. Ceyda Aslan Spec. MD. Ceyda Aslan Hematology Spec. MD. Elkhan Mammadov Spec. MD. Elkhan Mammadov Medical Oncology Spec. MD. Elmir İsrafilov Spec. MD. Elmir İsrafilov Hematology Spec. MD. Minure Abışova Eliyeva Spec. MD. Minure Abışova Eliyeva Hematology Spec. MD. Natavan Azizova Spec. MD. Natavan Azizova Medical Oncology Prof. MD. Mehmet Hilmi Doğu Liv Hospital Ulus + Liv Hospital Bahçeşehir Prof. MD. Mehmet Hilmi Doğu Hematology
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Evrim Duman Radiation Oncology

Assoc. Prof. MD. Evrim Duman

Liv Hospital Ulus
Asst. Prof. MD. Meltem Topalgökçeli Selam Medical Oncology

Asst. Prof. MD. Meltem Topalgökçeli Selam

Liv Hospital Ulus
Prof. MD. Duygu Derin Medical Oncology

Prof. MD. Duygu Derin

Liv Hospital Ulus
Prof. MD. Emre Merdan Fayda Radiation Oncology

Prof. MD. Emre Merdan Fayda

Liv Hospital Ulus
Prof. MD. Mehmet Hilmi Doğu Hematology

Prof. MD. Mehmet Hilmi Doğu

Liv Hospital Ulus
Liv Hospital Bahçeşehir
Prof. MD. Meral Günaldı Medical Oncology

Prof. MD. Meral Günaldı

Liv Hospital Ulus
Assoc. Prof. MD. Murat Ayhan Medical Oncology

Assoc. Prof. MD. Murat Ayhan

Liv Hospital Vadistanbul
Prof. MD.  Itır Şirinoğlu Demiriz Hematology

Prof. MD. Itır Şirinoğlu Demiriz

Liv Hospital Vadistanbul
Prof. MD. Tülin Tıraje Celkan Pediatric Hematology and Oncology

Prof. MD. Tülin Tıraje Celkan

Liv Hospital Vadistanbul
Assoc. Prof. MD. Erkan Kayıkçıoğlu Medical Oncology

Assoc. Prof. MD. Erkan Kayıkçıoğlu

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Mine Dağgez Gynecological Oncology

Assoc. Prof. MD. Mine Dağgez

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Ozan Balakan Medical Oncology

Assoc. Prof. MD. Ozan Balakan

Liv Hospital Bahçeşehir
MD. Taylan Bükülmez Radiation Oncology

MD. Taylan Bükülmez

Liv Hospital Bahçeşehir
Op. MD. Alp Koray Kinter Gynecological Oncology

Op. MD. Alp Koray Kinter

Liv Hospital Bahçeşehir
Prof. MD. Nuri Faruk Aykan Medical Oncology

Prof. MD. Nuri Faruk Aykan

Liv Hospital Bahçeşehir
Prof. MD. Yasemin Altuner Torun Pediatric Hematology and Oncology

Prof. MD. Yasemin Altuner Torun

Liv Hospital Bahçeşehir
Spec. MD. Özlem Doğan Medical Oncology

Spec. MD. Özlem Doğan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Emir Çelik Medical Oncology

Assoc. Prof. MD. Emir Çelik

Liv Hospital Topkapı
Assoc. Prof. MD. Muhammed Mustafa Atcı Medical Oncology

Assoc. Prof. MD. Muhammed Mustafa Atcı

Liv Hospital Topkapı
Prof. MD. İrfan Çiçin Medical Oncology

Prof. MD. İrfan Çiçin

Liv Hospital Topkapı
Assoc. Prof. MD.  Ramazan Öcal Hematology

Assoc. Prof. MD. Ramazan Öcal

Liv Hospital Ankara
Assoc. Prof. MD. Nazlı Topfedaisi Özkan Gynecological Oncology

Assoc. Prof. MD. Nazlı Topfedaisi Özkan

Liv Hospital Ankara
Prof. MD. Fikret Arpacı Medical Oncology

Prof. MD. Fikret Arpacı

Liv Hospital Ankara
Prof. MD. Gökhan Erdem Medical Oncology

Prof. MD. Gökhan Erdem

Liv Hospital Ankara
Prof. MD. Meral Beksaç Hematology

Prof. MD. Meral Beksaç

Liv Hospital Ankara
Prof. MD. Oral Nevruz Hematology

Prof. MD. Oral Nevruz

Liv Hospital Ankara
Prof. MD. Saadettin Kılıçkap Medical Oncology

Prof. MD. Saadettin Kılıçkap

Liv Hospital Ankara
Prof. MD. Sadık Muallaoğlu Medical Oncology

Prof. MD. Sadık Muallaoğlu

Liv Hospital Ankara
Spec. MD. Ender Kalacı Medical Oncology

Spec. MD. Ender Kalacı

Liv Hospital Ankara
Assoc. Prof. MD. Fadime Ersoy Dursun Hematology

Assoc. Prof. MD. Fadime Ersoy Dursun

Liv Hospital Gaziantep
Prof. MD. Fatih Teker Medical Oncology

Prof. MD. Fatih Teker

Liv Hospital Gaziantep
Spec. MD. ELXAN MEMMEDOV Medical Oncology

Spec. MD. ELXAN MEMMEDOV

Liv Bona Dea Hospital Bakü
Spec. MD. Ceyda Aslan Hematology

Spec. MD. Ceyda Aslan

Spec. MD. Elkhan Mammadov Medical Oncology

Spec. MD. Elkhan Mammadov

Spec. MD. Elmir İsrafilov Hematology

Spec. MD. Elmir İsrafilov

Spec. MD. Minure Abışova Eliyeva Hematology

Spec. MD. Minure Abışova Eliyeva

Spec. MD. Natavan Azizova Medical Oncology

Spec. MD. Natavan Azizova

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91